Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIDeS: Fulvestrant Dose-Titration in Advanced Breast Cancer
NCT00927511Phase 2Unknown
- Sponsor
- IRCCS Regina Elena National Cancer Institute
- Start
- Oct 2008
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in breast cancer, sponsored by IRCCS Regina Elena National Cancer Institute. Status: unknown.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00927511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00927511.